Guangwen "Gary" Ren, Ph.D.

Assistant Professor

To study tumor microenvironment and tumor immunology in cancer therapeutic resistance and metastatic relapse

My group mainly focuses on elucidating how mesenchymal lineage cells (mesenchymal stem cells and fibroblasts) and immune-regulatory myeloid cells (neutrophils and macrophages) modulate the adaptive immune responses in cancer treatment resistance and metastatic relapse. These studies will fully take advantage of the unique research platform--patient-derived xenograft (PDX) tumors in humanized mouse models at The Jackson Laboratory, with the research goal to develop novel strategies targeting tumor microenvironment to improve the efficacies of conventional cancer therapies and new therapeutics such as immunotherapy.

Gary Ren on Google Scholar



           Gary Ren on ORCID         



               Download CV              

Education and experience

Education

Princeton University
Postdoctoral Associate
Advisor: Dr. Yibin Kang
2012-2014

Rutgers University
Ph.D., Immunology
Advisor: Dr. Yufang Shi
2004-2009

Experience
The Jackson Laboratory
Assistant Professor
10/2016-present

Tufts University School of Medicine
Assistant Professor (joint appointment)
07/2017-present

University of Maine Graduate School of Biomedical Science and Engineering
Graduate Faculty Member
01/2017-present

Princeton University
Associate Research Scholar
2014-2016

Rutgers University Robert Wood Johnson Medical School
Research Teaching Specialist III
2009-2012

Grants, awards and accomplishments

2020 NIH/NCI The Method to Extend Research in Time (MERIT) (R37) Award
2018 DoD Breast Cancer Research Program Breakthrough Award
2014 NIH/NCI K99/R00 Pathway to Independence Award
2013 DoD Breast Cancer Research Program Postdoctoral Fellowship Award
2011 AAI (American Association of Immunologists) Meeting Trainee Abstract Award
2010 AAI (American Association of Immunologists) Meeting Trainee Abstract Award
2009 Best Poster Presentation Award for 5th International Conference on Mesenchymal and
non-Hematopoietic Stem Cells, Austin, TX, USA